BIOMAT Database Logo BIOMAT Database Logo

DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogs. 1996

M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Glaxo Wellcome Inc., Research Triangle Park, NC 27709, USA.

DNA polymerase activity was assayed in hepatitis B virus (HBV) and core particles isolated from chronic producer lines. The particle-associated DNA polymerase activity, which was found to be limited to incorporation of only a few nucleotides, was inhibited by the 5'-triphosphates of nucleoside analogs. The 1-beta-L (1S,4R) and 1-beta-D (1R,4S) enantiomers of antiviral nucleoside analogs were compared for the ability to inhibit incorporation of natural nucleoside triphosphates into the viral DNA. Previously, both enantiomers of several analogs were found to be substrates for human immunodeficiency virus type 1 reverse transcriptase (HIV RT); the 1-beta-D enantiomers of some pairs were preferred as substrates. In contrast, the 1-beta-L enantiomers of all pairs tested were the more potent inhibitors of labeled substrate incorporation into hepatitis B virus DNA; the concentration required to inhibit the incorporation of the natural substrate by 50% was 6-fold to several hundred-fold lower than the concentration of the 1-beta-D enantiomer required for the same inhibitory effect. This preference for the 1-beta-L enantiomers was observed for both RNA-directed synthesis in core particles and DNA-directed synthesis in viral particles. The observed antiviral effect of the nucleoside analogs in cell culture seemed to be limited chiefly by their phosphorylation in cells.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D003845 Deoxycytosine Nucleotides Cytosine nucleotides which contain deoxyribose as the sugar moiety. Deoxycytidine Phosphates,Nucleotides, Deoxycytosine,Phosphates, Deoxycytidine
D003848 Deoxyguanine Nucleotides Guanine nucleotides which contain deoxyribose as the sugar moiety. Deoxyguanosine Phosphates,Nucleotides, Deoxyguanine,Phosphates, Deoxyguanosine
D004259 DNA-Directed DNA Polymerase DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. DNA Polymerase,DNA Polymerases,DNA-Dependent DNA Polymerases,DNA Polymerase N3,DNA Dependent DNA Polymerases,DNA Directed DNA Polymerase,DNA Polymerase, DNA-Directed,DNA Polymerases, DNA-Dependent,Polymerase N3, DNA,Polymerase, DNA,Polymerase, DNA-Directed DNA,Polymerases, DNA,Polymerases, DNA-Dependent DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068679 Emtricitabine A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS. Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine,Coviracil,Emtriva,Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
D013698 Templates, Genetic Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES. Genetic Template,Genetic Templates,Template, Genetic

Related Publications

M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of hepatitis B Dane particle DNA polymerase activity by pyrophosphate analogs.
June 1980, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs.
December 1989, Antiviral research,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides.
December 1988, Journal of medical virology,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of hepatitis B virus DNA polymerase by 3'-fluorothymidine triphosphate and other modified nucleoside triphosphate analogs.
February 1990, Journal of medical virology,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of reverse transcriptase activity of hepatitis B virus polymerase by β-l-D4A-TP.
January 2008, Acta virologica,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents.
February 1980, Medical microbiology and immunology,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
November 1996, Hepatology (Baltimore, Md.),
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Inhibition of hepatitis B virus polymerase by entecavir.
April 2007, Journal of virology,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
Hepatitis B virus: DNA polymerase activity of deletion mutants.
February 1999, Biochemistry and molecular biology international,
M G Davis, and J E Wilson, and N A VanDraanen, and W H Miller, and G A Freeman, and S M Daluge, and F L Boyd, and A E Aulabaugh, and G R Painter, and L R Boone
[Hepatitis B virus DNA polymerase].
January 2001, Przeglad epidemiologiczny,
Copied contents to your clipboard!